Hyperprolactinemia: Clinical Trials

2 completed. 2 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	2	Completed 2

Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia Aripiprazole, Placebo - Hyperprolactinemia	Not applicable	Completed	University of Maryland, Baltimore	60	2011-01-01	2019-09-27
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment Metformin - Metabolic Disturbance, Hyperprolactinemia	Not applicable	Completed	Taipei Medical University Hospital	42	2010-05-31	2024-03-22

Narrower conditions

Schizophrenia (2)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Hyperpituitarism (2)  ·  Hypothalamic Diseases (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Pituitary Diseases (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)

Interventions

Aripiprazole (1)  ·  Metformin (1)

Sponsors

Taipei Medical University Hospital (1)  ·  University of Maryland, Baltimore (1)

Countries

Taiwan (1)  ·  United States (1)

Top investigators

Deanna L Kelly, Pharm.D., BCPP (1)  ·  Mong-Liang Lu, MD (1)